Results 91 to 100 of about 10,449 (205)

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score [PDF]

, 2017
Background The SYNTAX score (SXscore), an anatomical-based scoring tool reflecting the complexity of coronary anatomy, has established itself as an important long-term prognostic factor in patients undergoing percutaneous coronary intervention (PCI). The
Dawkins, Keith D., de Vries, Ton, Diletti, Roberto, Farooq, Vasim, Garcia-Garcia, Hector, Kappetein, Arie Pieter, Morel, Marie Angèle, Räber, Lorenz, Serruys, Patrick W., Steyerberg, Ewout W., Swart, Michael, Valgimigli, Marco, Vergouwe, Yvonne, Vranckx, Pascal, Windecker, Stephan   +14 more
core  

The safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume

Scientific Reports
This study aimed to evaluate the safety and efficacy of intra-arterial (IA) administration of low- dose tirofiban during endovascular therapy in patients with large ischemic core volumes on initial brain CT. Patients were divided into two groups based on
Kwang-Chun Cho, Nak-Hoon Son, So Hyeon Gwon, Jin Wook Choi, Woo Sang Jung   +4 more
doaj   +1 more source

Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy [PDF]

, 2011
Background Granulocyte colony-stimulating factor (G-CSF), a hematopoietic cytokine, was recently used to treat patients of acute myocardial infarction with beneficial effect.
Wei S Lian, Heng Lin, Winston TK Cheng, Tateki Kikuchi, Ching F Cheng   +4 more
core   +1 more source

The safety of enoxaparine use in elderly with acute myocardial infarction [PDF]

, 2007
Background/Aim. Enoxaparin (ENOX), the lowmolecular- weight heparin, used in acute myocardial infarction (AMI) could lead to hemorrhage. The aim of this study was to determine whether bleeding was more often in AMI patients older than 65 or 75 years who ...
Despotović Nebojša, Dimković Siniša, Ilić Marjan, Lončar Goran, Nikolić-Despotović Maja   +4 more
core   +1 more source

Gene mutations of platelet glycoproteins and response to tirofiban in acute coronary syndrome

São Paulo Medical Journal
CONTEXT AND OBJECTIVES: Glycoprotein inhibitors (abciximab, eptifibatide and tirofiban) are used in patients with unstable angina and non-ST-segment elevation myocardial infarction before percutaneous coronary intervention.
Antonio de Padua Mansur, Alessandra Roggerio, Júlio Yoshio Takada, Pérola Michelle Vasconcelos Caribé, Solange Desirée Avakian, Célia Maria Cassaro Strunz   +5 more
doaj   +1 more source

Bivalirudin started during emergency transport for primary PCI. [PDF]

, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +1 more source

Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. [PDF]

, 2008
OBJECTIVE: Staphylococcus aureus is the most frequent causative organism of infective endocarditis (IE) and is characterized by thrombus formation on a cardiac valve that can embolize to a distant site. Previously, we showed that S.
Clarke, Niamh, Cox, Dermot, Foster, Timothy J, Kerrigan, Steven W, Loughman, Anthony, Meade, Gerardene   +5 more
core  

Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives.

PLoS ONE
BackgroundThe RESCUE BT2 trial recently showcased the efficacy of tirofiban in treating acute ischemic stroke (AIS) without large or medium-sized vessel occlusion.
Li Wang, Yuhong Zeng, Limei Zhou, Ping Xu, Xianbin Guo, Yu Xie, Junxiu Cai, Min Pan, Jie Tang, Qingtao Gong, Rong Su, Yan Liu, Yake Lou   +12 more
doaj   +1 more source

Tirofiban-induced acute profound thrombocytopenia in endovascular therapy for acute ischemic stroke: a rare case report

BMC Neurology
Background Studies have shown that tirofiban (a glycoprotein IIb/IIIa receptor antagonist) is effective in the endovascular treatment of cerebrovascular diseases. However, it has also been reported that tirofiban can cause thrombocytopenia.
Jiuling Liu, Melysze Deanne Oorloff, Adithya Nadella, Yun Yan, Ning Zhou   +4 more
doaj   +1 more source

Desenlaces clínicos en una cohorte de pacientes con síndrome coronario agudo y administración intracoronaria de tirofiban

Revista Colombiana de Cardiología, 2015
Introducción: Los inhibidores de glicoproteína IIb/IIIa reducen los eventos cardiovasculares mayores adversos (MACE) en pacientes con síndrome coronario agudo.
Julián Ochoa, Jorge G. Velásquez, Jorge A. Cedano, Camila Ospina, Lina Merchancano, Diana C. Carrillo   +5 more
doaj   +1 more source